modere glp-1 CURB Sets a New Standard in Weight Loss and Appetite Suppression Supplements Modere Announces Launch of Body

China is Next Big Market: Manufacturing Challenges, Supply Shortages

Five medical societies have united on guidance and two recent studies shed new light on the topic.

GLP-1 receptor agonists like semaglutide can slow gastric emptying, potentially reducing birth control pill absorption and effectiveness

We also discuss combination therapies and strategies to mitigate muscle mass loss during treatment and calls for targeted research, improved clinical education, and policy reforms to optimize the translational potential of GLP-1R agonists in both individualized care and population health

Repatha (evolocumab) is a PCSK9 inhibitor that cuts LDL by ~60% when statins aren't enough

For humans, the model-predicted median clearance (CL) and volume of distribution (Vss) of semaglutide were 0.0397 L/h and 6.23 L, respectively